NFL Collective Bargaining Agreement
Players’ Rights To Medical Care and Treatment
Section 14(d)Club-Wide Biospecimen Collection
For purposes of this Section “Club- Biospecimen Collection” shall mean any effort to collect, monitor, analyze information on or in connection with the blood, urine or other biospecimen. The provisions of this Section shall not affect a Club physician’s ability to order blood or other biospecimen collection and/or testing of an individual player when he or she determines it is clinically indicated (e.g., to determine if such player is suffering from a medical condition at the player’s request or based on the physician’s clinical judgment). NFL Clubs may not perform Club Biospecimen Collection without the prior written approval of the NFL Players Association. Approved Club Biospecimen Collection is subject to the following limitations:
Information arising from a Club Biospecimen Collection and transferred to the Club shall not be used by the Club or any third-party for any purpose other than supporting player health and/or performance. If a player consents to transfer data to his Club, the receiving Club shall not transfer player data to the NFL, any other NFL Club, or other third-party. Clubs must have policies in place that ensure the confidentiality, privacy, and security of any and all data/information collected during Club Biospecimen Collections. Clubs must ensure that all those involved, directly or indirectly, in a Club Biospecimen Collection take all appropriate steps to protect personally identifiable information of the player participants from disclosure and ensure compliance with all applicable laws. No data/information collected during a Club Biospecimen Collection may be sold or transferred to third parties.